Overview
Financials
The financial statement for 2023 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2022.
Results vs industry
Industry
Bank accounts
Was a VAT taxpayer from 2020-07-01 to 2024-08-12. Removed from VAT register
Reason for removal: Art. 96 ust. 9 pkt 2 (contact with the taxpayer or their representative is impossible despite documented attempts)
Debt
2 closed proceedings recorded in KRZ history. Closed proceedings in history
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Mar 31, 2025 | Discontinued enforcement proceedings | Closed | |
| Mar 31, 2025 | Discontinued enforcement proceedings | Closed |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Aug 9, 2023 | Call to creditors |
Public aid
6 public aid cases recorded, with a total value of $464,439.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 29, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) Mar 29, 2022 · Fundacja Klaster Lifescience Kraków | $4,933$4,933 | Fundacja Klaster Lifescience Kraków | |
| Jan 14, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) Jan 14, 2022 · Fundacja Klaster Lifescience Kraków | $3,234$3,234 | Fundacja Klaster Lifescience Kraków | |
| Nov 30, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) Nov 30, 2021 · Fundacja Klaster Lifescience Kraków | $3,103$3,103 | Fundacja Klaster Lifescience Kraków |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
Each member of the management board is authorised to make declarations of will on behalf of the company independently. In the case of a multi-member management board, two members of the management board acting jointly, or a member of the management board together with a commercial proxy, are authorised to make declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 110 | $1,485.68 | 23.2558% | |
Łukasz Makowski (50) | 190 | $2,566.18 | 40.1691% |
Others | 173 | $2,336.57 | 36.5751% |
Beneficial owners
| Person | Rights |
|---|---|
Mateusz Marek Kierepka (52)  | Shareholder of a limited liability company, 9200.0 PLN |
Łukasz Makowski (50) | Shareholder of a limited liability company, 9200.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Euro-Medicasp. z o.o. Revenue: $8,023,306.66 · euro-medica.pl | $8,023,306.66 | euro-medica.pl | |
| Zapytaj Lekarzasp. z o.o. Revenue: $925,661.48 · zapytaj-lekarza.pl | $925,661.48 | zapytaj-lekarza.pl | |
| Insignissp. z o.o. Revenue: $729,051.08 · centruminsignis.pl | $729,051.08 | centruminsignis.pl | |
| Medica Laser Pjsp. z o.o. Revenue: $217,558.85 · medicalaserswarzedz.pl | $217,558.85 | medicalaserswarzedz.pl | |
| EYE Zonesp. z o.o. Revenue: $240,919.84 · eyezone.pl | $240,919.84 | eyezone.pl | |
| Centrum Konsyliumsp. z o.o. Revenue: $240,129.25 · centrum-konsylium.pl | $240,129.25 | centrum-konsylium.pl | |
| Centrum Medycyny KonopnejS.A. Revenue: $204,759.22 · centrum-mk.pl | $204,759.22 | centrum-mk.pl | |
| Akademickie Centrum Badań Akamedsp. z o.o. Revenue: $223,061.46 · akamed.umk.pl | $223,061.46 | akamed.umk.pl | |
| Terapposp. z o.o. Revenue: $48,218.49 · terappo.pl | $48,218.49 | terappo.pl | |
| Dietetyka Specjalistycznasp. z o.o. Revenue: $8,072.65 · dietetykaspecjalistyczna.eu | $8,072.65 | dietetykaspecjalistyczna.eu |
Change history
| Date | Event |
|---|---|
| 2024-02-26 | Share capital change (31,700.00 PLN → 23,650.00 PLN) |
| 2024-01-25 | Share capital change (30,600.00 PLN → 31,700.00 PLN) |
| 2022-03-29 | Share capital change (29,100.00 PLN → 30,600.00 PLN) |
| 2021-08-20 | Share capital change (7,450.00 PLN → 29,100.00 PLN) |
| 2021-08-20 | PKD change (Added: 47, 62, 63, 71, 73, 85) |
FAQ
Last updated: 2026-04-15